Confused between eczema and psoriasis? Experts explain how these skin conditions differ in symptoms, causes, and treatment.

A TYK2 inhibitor in development shows superior efficacy to placebo and apremilast for treating psoriasis, with no new safety ...

Psoriasis is a long-term skin condition that affects millions of people around the world. It causes red, dry, and scaly ...

Even though having an itch is innocuous, the underlying reason you have the itch in the first place could be more disgusting ...

Envudeucitinib achieved robust PASI responses by Week 16, with significant continued improvements by Week 24 in PASI 90 (68.0%, 62.1%) and PASI ...

Organon recently presented post-hoc pooled Phase 3 ADORING 1 and 2 data showing VTAMA cream achieved early, statistically significant improvements in atopic dermatitis severity and itch versus vehicle ...

Envudeucitinib achieved robust PASI responses by Week 16, with significant continued improvements by Week 24 in PASI 90 (68.0%, 62.1%) and PASI 100 (41.0%, 39.5%)Quality‑of‑life improvements and itch ...

Spongiotic dermatitis is a pathological term that refers to a non-contagious skin inflammation, which is often present in eczema, dermatitis, and allergic contact dermatitis.

Mar 28, 2026-- Takeda ( TSE:4502/NYSE:TAK ) today announced new data from the two pivotal Phase 3 studies of zasocitinib (TAK-279 ...

A healthy skin is not only a matter of appearance becuase itchy and inflamed skin may impact sleep, mood and overall ...

71.4% and 69.2% of patients treated with zasocitinib achieved a static Physician Global Assessment (sPGA) score of 0/1 versus placebo (10.7% and 12.6%) and apremilast (32.1% and 29.7%) at week 16 (p<0 ...

Alumis (NASDAQ:ALMS) used a virtual key opinion leader event from the American Academy of Dermatology (AAD) Congress to ...